Features May 2007 Issue

Will Drugs Someday Reverse CAD?

Three recent advances bring the possibility closer to reality.

Coronary artery disease (CAD) traditionally has been thought of as a progressive disease. Medical therapies have aimed at slowing its progression to reduce the risk of heart attack. A drug that could actually shrink plaque in the arteries was considered a dream. But clinical trials of three different approaches indicate that this dream may become a reality within our lifetime.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.